topotecan ch topotecan (as hydrochloride) 4 mg powder for injection vial
alphapharm pty ltd - topotecan hydrochloride -
topotecan mylan topotecan (as hydrochloride) 4 mg powder for injection vial
alphapharm pty ltd - topotecan hydrochloride -
topotecan intas topotecan (as hydrochloride) 1 mg/1 ml concentrated injection vial
accord healthcare pty ltd - topotecan hydrochloride, quantity: 1.09 mg (equivalent: topotecan, qty 1 mg) - injection, concentrated - excipient ingredients: hydrochloric acid; water for injections; tartaric acid; sodium hydroxide - topotecan intas is indicated as single agent therapy for the treatment of patients with:,? small cell lung carcinoma after failure of first line chemotherapy.,? metastatic carcinoma of the ovary after failure of first-line or subsequent therapy.,topotecan intas is indicated in combination with cisplatin for the treatment of patients with:,? histologically confirmed stage iv-b, recurrent, or persistent carcinoma of the cervix, which is not amenable to curative treatment with surgery and/or radiation therapy.
topotecan medison 4 mg
medison pharma ltd - topotecan hydrochloride 4 mg/vial - powder for concentrate for infusion - topotecan - treatment of metastatic carcinoma of the ovary after failure of initial or subsequent therapy.treatment of small cell lung cancer sensitive disease after failure of first line chemotherapy. topotecan in combination with cisplatin is indicated for the treatment of stage iv-b recurrent or persistent carcinoma of the cervix which is not amenable to curative treatment with surgery and/or radiation therapy.
topotecan kabi
fresenius kabi australia pty limited - topotecan hydrochloride -
hycamtin 0.25 mg
novartis israel ltd - topotecan as hydrochloride - hard gelatin capsules - topotecan as hydrochloride 0.25 mg - topotecan - topotecan - indicated for the treatment of patients with relapsed small cell lung cancer (sclc) for whom re-treatment with the first-line regimen is not considered appropriate.
hycamtin 1 mg
novartis israel ltd - topotecan as hydrochloride - hard gelatin capsules - topotecan as hydrochloride 1 mg - topotecan - topotecan - indicated for the treatment of patients with relapsed small cell lung cancer (sclc) for whom re-treatment with the first-line regimen is not considered appropriate.
hycamtin topotecan (as hydrochloride) 4mg powder for injection vial
sandoz pty ltd - topotecan hydrochloride, quantity: 4 mg - injection, powder for - excipient ingredients: sodium hydroxide; tartaric acid; hydrochloric acid; mannitol - for single agent therapy for the treatment of patients with: small cell lung carcinoma, after failure of first line chemotherapy. metastatic carcinoma of the ovary after failure of first-line or subsequent therapy. in combination with cisplatin for the treatment of patients with: histologically confirmed stage iv-b, recurrent, or persistent carcinoma of the cervix which is not amenable to curative treatment with surgery and/or radiation therapy.
potactasol
actavis group ptc ehf - topotecan - uterine cervical neoplasms; small cell lung carcinoma - antineoplastic agents - topotecan monotherapy is indicated for the treatment of:- patients with metastatic carcinoma of the ovary after failure of first-line or subsequent therapy- patients with relapsed small cell lung cancer (sclc) for whom re-treatment with the first-line regimen is not considered appropriate (see section 5.1).topotecan in combination with cisplatin is indicated for patients with carcinoma of the cervix recurrent after radiotherapy and for patients with stage ivb disease. patients with prior exposure to cisplatin require a sustained treatment free interval to justify treatment with the combination (see section 5.1).
hycamtin topotecan hydrochloride capsule
glaxosmithkline llc - topotecan hydrochloride (unii: 956s425zcy) (topotecan - unii:7m7ykx2n15) - topotecan 0.25 mg